All comments are welcome from Presentation : Rapinyl (cancer Pain) Phase III – US, Jap,Registration -EU (peak sales 500 million US$ Sublinox (Insomnia) US-NDA in Jan 2008 (peak sales 350 million US$) OX 17 (GERD) Phase III results in 1H 2008 US/EU (peak sales 1 billion US$) BLX-NLA (Rhinitis) start Phase III in 1H 2008 (peak sales 300 million US$)